Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma
Clinical trial NCT07375563 · RECRUITING
Trial details
- NCT number
- NCT07375563
- Sponsor
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-19
- Primary completion
- 2026-12-15
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.